Weight loss is a famous side effect of Ozempic, the Type 2 diabetes drug, but patients often find they must avoid certain foods on the medication.
- May 09, 2024Source: Weight Watchers
After more than 60 years of watching weight, we think it’s time to shift the role weight plays in our society. Dr. Ania Jastreboff is an endocrinologist and associate professor at the Yale School of Medicine. In this video, recorded during Oprah’s “Making the Shift: A New Way to Think About Weight,” she explains why obesity is defined as “a disease” (a neurometabolic disease, to be specific) and why that’s important for addressing its causes and treatments. She also discusses the facts and fiction about weight loss medications and why the option might be (or might not be) explored for some of her patients - and how you, and only you, can make the decision about what’s best for your health.
- May 02, 2024
More than 300 Yale Medicine physicians have earned a spot on the 2024 Connecticut Magazine “Top Doctors” list.
- April 12, 2024
The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.
- March 18, 2024
Yale Cancer Center (YCC) and Smilow Cancer Hospital physicians and scientists will share new data for breakthrough and emerging cancer treatments as well as new discoveries in obesity, tobacco, evolution, and early onset cancers in early April at the American Association for Cancer Research (AACR) annual meeting.
- March 11, 2024Source: Yale Medicine
The FDA’s approval of Wegovy could help millions of Americans with both obesity and cardiovascular disease lower their risk of having a major cardiac event.
- March 06, 2024
Newly emerging, highly effective treatments and new discoveries regarding the pathophysiology of obesity provide promise for combating this growing epidemic.
- February 26, 2024Source: NBC Connecticut
Ania Jastreboff, MD, PhD, associate professor of medicine (endocrinology and metabolism), has been leading pivotal trials to test anti-obesity medications.
- February 05, 2024
In a Q&A, Ania Jastreboff, MD, PhD, discusses the barriers to treating obesity, benefits of clinical trials, and the new era of obesity medicine.
- January 19, 2024Source: Today
Ania Jastreboff, MD, PhD, associate professor of medicine (endocrinology), talks about the decreased hunger patients may experience when taking Ozempic or Wegovy.